A molecular jackhammer approach destroyed up to 99% of melanoma cells in laboratory testing without relying on chemotherapy drugs. The experimental method uses rapid mechanical vibrations to rupture cancer-cell membranes.
The result offers an early indication that cancer cells may be attacked through a physical mechanism rather than a conventional chemical treatment. However, the technology remains preclinical and is not available as a treatment for human patients.
How the Molecular Jackhammer Works
The method uses synthetic aminocyanine molecules, compounds previously known as dyes for medical imaging. These molecules are activated with near-infrared light.
Once exposed to that light, the aminocyanine molecules vibrate together at extremely high frequencies. The resulting mechanical force can tear open the cancer-cell membrane, causing the cell to lose its structure and die.
This mechanism differs from chemotherapy, which uses chemical substances to kill cancer cells. Researchers see the physical approach as a possible foundation for a more targeted generation of cancer treatments.
Near-Infrared Light Could Improve Targeting
Near-infrared light is central to the approach because it can penetrate body tissue more deeply than visible light. That capability could make it possible to activate the destructive molecules in the tumor area without major invasive surgery.
Because the molecules are activated by light, the treatment is designed to act at the intended location. This may help reduce damage to healthy tissue surrounding a tumor compared with methods that act more broadly throughout the body.
Researchers also believe cancer cells may find it more difficult to develop resistance to a mechanical attack. Drug resistance remains one of the recurring challenges in cancer treatment.
| Testing Stage | Test Subject | Reported Result |
|---|---|---|
| Laboratory test | Melanoma cells | Up to 99% of cancer cells destroyed |
| Preclinical test | Mice | About 50% were reported cancer-free |
Promising Results, but Not Human Evidence
In the laboratory, the technology was tested on melanoma cells, a type of skin cancer. The 99% figure describes a result under test conditions and does not represent a treatment success rate in humans.
In mouse studies, about half of the animals receiving the experimental therapy were reported to be cancer-free. The finding gives researchers a basis to continue examining how the molecular jackhammer could be applied.
Further Clinical Testing Is Required
Strong early findings do not mean the molecular jackhammer can replace chemotherapy or other cancer therapies. Human clinical trials are still needed to assess safety, appropriate dosage, long-term effectiveness, and possible side effects.
The research was conducted by scientists from Rice University, Texas A&M University, and the University of Texas. The findings were published in Nature Chemistry, according to Media Indonesia.
Future evaluations will determine whether this vibration-based method can become a safe and effective oncology option. Until then, the technology should be viewed as a promising experimental development rather than an established treatment.
